Real Time Data Exchange

 

Please join us for these topic-specific research discovery sessions covering ViiV-sponsored clinical data, presented virtually at the AIDS 2020 23rd International AIDS Conference from July 6-20, 2020.

Cabotegravir Long-acting for Prevention – HPTN 083 study

Please join with ViiV Senior Medical Experts in the discussion of the final results from the HPTN 083 study evaluating the use of cabotegravir for PrEP
Alex Rinehart, PhD and David Margolis MD, MPH

Neural Tube Defects Update from Tsepamo

Please join with ViiV Senior Medical Experts in the discussion of updates on neural tube defects with antiretroviral exposure from the AIDS 2020 meeting
Jean Van Wyk, MBChB

Treatment-experienced data: TANGO study Target Not Detected analysis

Please join with ViiV Senior Medical Experts in the discussion of real world efficacy data with Dovato presented at the AIDS 2020 meeting
Jean Van Wyk, MBChB

Weight gain and metabolic health

Please join with ViiV Senior Medical Experts in the discussion of metabolic health and weight gain with Dovato presented at the AIDS 2020 meeting
Jean Van Wyk, MBChB

Are you a US healthcare provider?

This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.

If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.

Connect With Our Medical Experts

Find My ViiV MSL

Easily find the ViiV Medical Science Liaison (MSL) in your area.

Request a Scientific Discussion

Submit a request for additional information from a ViiV Medical Expert.

Contact Us

Chat Live

Get immediate assistance from a ViiV Healthcare Professional.

Call 1‑888‑226‑8434

Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)

Report an Adverse Event

To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1‑877‑844‑8872 or FDA at 1‑800‑332‑1088 or www.fda.gov/medwatch